Trinity Biotech sets Sept. 30, 2026 AGM vote
Trinity Biotech PLC schedules its 2026 AGM to vote on auditor matters and the re-appointment of director Dr Andrew Omidvar.
Rhea-AI Filing Summary
TRINITY BIOTECH PLC (TRIB) reports that its 2026 Annual General Meeting will be held at its registered office in Bray, County Wicklow, Ireland, on September 30, 2026 at 10:00 am. Shareholders will vote on reappointing Grant Thornton as statutory auditor, authorising the Board to fix the auditors’ remuneration, and re-appointing Dr Andrew Omidvar as a director.
The company explains voting procedures for both registered shareholders and holders of American Depositary Receipts, including proxy submission, the use of a poll for each resolution, and that the record date is September 1, 2026. The 2025 Annual Report and AGM materials are furnished as exhibits and incorporated by reference into existing registration statements.
Positive
- None.
Negative
- None.
Key Figures
Key Terms
Form 6-K regulatory
Annual General Meeting regulatory
American Depositary Receipt financial
record date financial
poll regulatory
FAQ
When is TRINITY BIOTECH PLC (TRIB) holding its 2026 Annual General Meeting?
What key resolutions will be voted on at TRIB’s 2026 AGM?
What is the record date for voting at TRINITY BIOTECH PLC’s 2026 AGM?
How are American Depositary Receipt holders of TRIB able to vote at the AGM?
By when must proxies be lodged for TRINITY BIOTECH PLC’s 2026 AGM?
AI-generated analysis. How Rhea-AI works. Not financial advice.
|
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
F O R M 6-K
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the month of September 2026
TRINITY BIOTECH PLC
(Name of Registrant)
IDA Business Park
Bray, Co. Wicklow, Ireland
(Address of Principal Executive Office)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
Form 20-F ☒ Form 40-F ☐
This Form 6-K is being incorporated by reference into our Registration Statements on Form S-8 (File Nos. 333-182279, 333-195232 and 333-253070) and Form F-3 (File Nos. 333-267160, 333-286020, 333-295842 and 333-280391).
EXPLANATORY NOTE
A copy of the Trinity Biotech plc Annual Report 2025 is furnished herewith as Exhibit 99.1.
Trinity Biotech plc sent holders of its Ordinary Shares the following: “Letter from the Company Secretary of Trinity Biotech plc“, “Notice of Annual General Meeting“ and “Form of Proxy“. Copies of these documents are filed herewith as Exhibit 99.2, Exhibit 99.3 and Exhibit 99.4 and incorporated herein by reference.
EXHIBIT INDEX
Exhibit |
| Description |
|
|
|
99.1 |
| Trinity Biotech plc Annual Report 2025 |
99.2 |
| Trinity Biotech plc Company Secretary Letter |
99.3 |
| Trinity Biotech plc Notice of Annual General Meeting |
99.4 |
| Trinity Biotech plc AGM Proxy Card |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| TRINITY BIOTECH PLC |
| |
|
| Trinity Biotech plc |
|
|
| (Registrant) |
|
|
|
|
|
| By: | /s/ Paul Murphy |
|
|
| Paul Murphy |
|
|
| Interim Chief Financial Officer |
|
Date: September 8, 2026
|
|
Exhibit 99.2
TRINITY BIOTECH PLC
(Incorporated and registered in Ireland with registered number 183476)
4 September 2026
Dear Shareholder,
Annual General Meeting of Trinity Biotech plc (the “Company”)
The board of directors (the “Board”) of the Company encloses notice of an annual general meeting of the Company, to be held at the Company’s registered office at IDA Business Park, Bray, County Wicklow, Ireland, A98 H5C8, on 30 September 2026 at 10:00 am (the “AGM”).
Business of Annual General Meeting
We would like to take this opportunity to provide some additional information in relation to the various items of business which are to be considered at the AGM.
Ordinary Business
Resolution 1 deals with the reappointment of Grant Thornton as statutory auditor of the Company to hold office until the conclusion of the next annual general meeting at which accounts are laid before the Company.
Resolution 2 seeks to authorise the Board to fix the statutory auditors’ remuneration.
Resolution 3 proposes the re-appointment of Dr Andrew Omidvar as a director who retires at the AGM and, being eligible, offers himself for re-appointment. Dr Omidvar has over twenty-five years of experience leading cross-functional teams to deliver cuttingedge technology solutions in a variety of industries. He brings experience in development and product support for data and AI based systems in the medical device industry. Most recently Dr Omidvar served as Vice President of Government R&D and Enterprise for Philips.
How to Vote
ADS holders
If you have an interest in A ordinary shares, par value $0.0001, (“Ordinary Shares”) in ADS form (i.e., your shares are held as American Depository Shares through the program’s depositary, The Bank of New York Mellon (“BNY”)), you will receive voting instructions: (i) from BNY directly, in the case of registered holders of ADSs (sometimes referred to as holding ADSs “of record”), or (ii) in the case of ADSs held beneficially (ie, “in street”), from your broker. You must follow the instructions received in order to vote your shares.
Registered Ordinary Shareholders
For those registered holders of Ordinary Shares who are not attending the meeting, we would strongly encourage you to vote your shares by completing, signing and returning the enclosed form of proxy as soon as possible. To be valid, forms of proxy duly signed together with the power of attorney or such other authority (if any) under which they are signed (or certified copy of such power or authority), must be lodged with Computershare Investor Services Ireland, 3100 Lake Drive, Citywest Business Campus, Dublin 24, D24 AK82, Ireland, not later than 28 September 2026 at 10:00 am (or in the case of an adjournment, 48 hours before the time appointed for the holding of the meeting).
Please follow the simple instructions set forth on the proxy card you receive to vote your shares.
Recommendation
The Board is satisfied that the resolutions set out in the notice of AGM are in the best interests of the Company and its shareholders. Accordingly, the Board unanimously recommends that you vote in favour of each of the resolutions as they intend to do in respect of all the shares which can be voted by them.
Board changes
In anticipation of the forthcoming AGM, Mr Ronan O’Caoimh (founder, former Chief Executive Officer and former Chairman) stood down from the board after more than 30 years. The Company would like to thank Mr O’Caoimh for his service and wish him well for the future.
As always, we thank you for your continued support.
John Gillard
Company Secretary and Chief Executive Officer
4 September 2026
Directors: Directors: John Gillard, Andrew Omidvar PhD, John Paul Tivnan and Paul Murphy
Registered office: IDA Business Park, Bray, County Wicklow, Ireland
|
|
Exhibit 99.3
TRINITY BIOTECH PLC
(Incorporated and registered in Ireland with registered number 183476)
NOTICE OF ANNUAL GENERAL MEETING OF SHAREHOLDERS TO BE HELD ON 30 SEPTEMBER 2026 AT 10:00 AM
Notice is hereby given that an annual general meeting of Trinity Biotech plc (the “Company”) will be held at the Company’s registered office at IDA Business Park, Bray, County Wicklow, Ireland, A98 H5C8, on 30 September 2026 at 10:00am for the following purposes:
Ordinary Business
1. To re-appoint Grant Thornton as statutory auditor of the Company to hold office until the conclusion of the next annual general meeting at which accounts are laid before the Company.
2. To authorise the board of directors to fix the statutory auditors’ remuneration.
3. To re-appoint Dr Andrew Omidvar as a director who retires, and, being eligible, offers himself for re-appointment.
During the AGM, the Board will present, for consideration by the shareholders, the Company’s statutory financial statements under Irish law for the fiscal year ended December 31, 2025 (including the reports of the directors and the Irish statutory auditor thereon) and a review of the Company’s affairs.
By order of the Board
John Gillard
Company Secretary
Notes:
1. Where used in this Notice the expressions “American Depositary Receipt” or “ADR” means an American depositary receipt evidencing one or more American depositary share(s), each of which in turn represents six hundred A Ordinary Shares.
2. Any member entitled to attend and vote at this meeting may appoint a proxy who need not be a member of the Company to attend, speak and vote in his/her place. Completion of the enclosed form of proxy will not affect the right of a member to attend and vote at this meeting in person.
3. To be valid, forms of proxy duly signed together with the power of attorney or such other authority under which they are signed (or certified copy of such power or authority), must be lodged with Computershare Investor Services Ireland, 3100 Lake Drive, Citywest Business Campus, Dublin 24, D24 AK82, Ireland, not later than 28 September 2026 at 10:00 am (or in the case of an adjournment, 48 hours before the time appointed for the holding of the meeting).
4. The record date for the annual general meeting is 1 September 2026. Only those shareholders on the register of members and holders of ADRs at close of business on that date are entitled to vote at the annual general meeting or at any adjournment or postponement thereof.
5. ADR holders may instruct the ADR depositary, The Bank of New York Mellon (BNY), as to the way in which the shares represented by their ADRs should be voted by completing and returning the voting card provided by BNY in accordance with the instructions delivered by BNY to ADR holders.
6. Voting on each of the resolutions will be decided on a poll. This means that shareholders who do not attend the annual general meeting in person but have validly submitted a form of proxy will have their votes taken into account according to the number of shares they hold.
7. All references to time in this Notice are to Irish Standard Time (as set out in the Standard Time Act 1968 and the Standard Time (Amendment) Act 1971).
8. The board reserves the right to withdraw any resolution contained in this Notice from the business of the AGM at any time up to the commencement of the AGM.
9. Board Practices, Corporate Governance and Compensation of Certain Executive Officers and Directors:
Item 6.B (“Compensation”) of our Annual Report on Form 20-F for the year ended December 31, 2025 (which we refer to as our 2025 Form 20-F), contains information regarding compensation paid to our directors and certain office holders with respect to 2025. Item 6.C of our 2025 Form 20-F (“Board ractices”) contains additional information regarding our Board, its committees and our corporate governance practices.
We encourage you to review those portions of our 2025 Form 20-F, which we incorporate by reference herein (and for which we have provided a general link below), to obtain additional information:
https://www.sec.gov/ix?doc=/Archives/edgar/data/0000888721/000155485526000848/trib-20251231.htm
Directors: Directors: John Gillard, Andrew Omidvar PhD, John Paul Tivnan and Paul Murphy
Registered office: IDA Business Park, Bray, County Wicklow, Ireland
|
|
Exhibit 99.4
SRN:
Trinity Biotech plc
(the “Company”)
Form of Proxy
For use at the annual general meeting to be held at the Company’s registered office at IDA Business Park, Bray, County Wicklow, Ireland, A98 H5C8, on 30 September 2026 at 10:00 am (the “Annual General Meeting”).
I/We ________________________________________________________________
(BLOCK LETTERS)
of ________________________________________________________________
being a member/members of the above Company hereby appoint the chairman of the Annual General Meeting.
*or __________________________________________________________
as my/our proxy to attend, speak, vote and to demand or join in demanding a poll for me/us on my/our behalf at the said meeting of the Company to be held at 10:00 am on 30 September 2026 and at any adjournment thereof.
I/We direct that my/our vote(s) be cast on each specified resolution as indicated by an X in the appropriate box below.
This proxy may be exercised in respect of all / ____________** shares registered in my/our name(s).
*If it is desired to appoint another person as proxy, these words should be deleted and the name and address of the proxy, who need not be a member of the Company be inserted.
**Where a proxy is not to have the authority to vote all shares registered in the name of the member/members, the member/members should specify the number of shares which may be voted by the proxy, where indicated above. Where the number of shares is not inserted, a proxy will be deemed to have authority to vote all of the shares registered in the member’s/members’ name(s).
RESOLUTIONS | For | Against | Withheld |
|
|
|
|
Resolution 1 Reappointment of statutory auditor. | | | |
Resolution 2 Remuneration of statutory auditor. | | | |
Resolution 3 Re-appointment of Dr Andrew Omidvar as a director of the Company. | | | |
Dated this day of September 2026
Signature _____________________________
Notes:
1. Where used in this Notice the expressions “American Depositary Receipt” or “ADR” means an American depositary receipt evidencing one or more American depositary share(s), each of which in turn represents six hundred A Ordinary Shares.
2. Any member entitled to attend and vote at this meeting may appoint a proxy who need not be a member of the Company to attend, speak and vote in his/her place. Completion of the enclosed form of proxy will not affect the right of a member to attend and vote at this meeting in person.
3. To be valid, forms of proxy duly signed together with the power of attorney or such other authority under which they are signed (or certified copy of such power or authority), must be lodged with Computershare Investor Services Ireland, 3100 Lake Drive, Citywest Business Campus, Dublin 24, D24 AK82, Ireland, not later than 28 September 2026 at 10:00 am (or in the case of an adjournment, 48 hours before the time appointed for the holding of the meeting).
4. The record date for the annual general meeting is 1 September 2026. Only those shareholders on the register of members and holders of ADRs at close of business on that date are entitled to vote at the annual general meeting or at any adjournment or postponement thereof.
5. ADR holders may instruct the ADR depositary, The Bank of New York Mellon (BNY), as to the way in which the shares represented by their ADRs should be voted by completing and returning the voting card provided by BNY in accordance with the instructions delivered by BNY to ADR holders.
6. Voting on each of the resolutions will be decided on a poll. This means that shareholders who do not attend the annual general meeting in person but have validly submitted a form of proxy will have their votes taken into account according to the number of shares they hold.
7. All references to time in this Notice are to Irish Standard Time (as set out in the Standard Time Act 1968 and the Standard Time (Amendment) Act 1971).
8. The board reserves the right to withdraw any resolution contained in the notice of meeting from the business of the Annual General Meeting at any time up to the commencement of the Annual General Meeting.
9. The proxy appointed shall not vote or attempt to exercise the right to vote attached to the shares, other than in accordance with instructions set out in this form of proxy. The proxy shall not have the right to vote the shares on any matter that comes before the meeting other than those specifically set out in the notice of meeting.
|